2006
DOI: 10.1016/j.ijpharm.2006.05.027
|View full text |Cite
|
Sign up to set email alerts
|

Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
213
0
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 347 publications
(226 citation statements)
references
References 54 publications
10
213
0
3
Order By: Relevance
“…Transfersomes containing EGCG alone (EGCG-TF) showed a significantly higher (p50.05) EGCG deposition in skin (28.49 ± 1.74 mg/cm 2 ) than that observed with plain EGCG solution. Similar observation has been reported in previous literature where transfersomes increased the skin deposition of drugs like cyclosporin A, estradiol, dipotassium glycyrrhizinate, dexamethasone and ketotifen along with enhancement in permeation rate in their transfersomal forms due to transcutaneous hydration gradient (Maghraby et al, 1999;Guo et al, 2000;Trotta et al, 2002;Jain et al, 2003;Elsayed et al, 2007). Further enhancement in skin deposition of EGCG (38.90 ± 1.16 mg/cm 2 ) was observed with the transfersomal formulation containing both EGCG as well as HA (ETF20).…”
Section: In Vitro Skin Permeation and Deposition Studysupporting
confidence: 89%
“…Transfersomes containing EGCG alone (EGCG-TF) showed a significantly higher (p50.05) EGCG deposition in skin (28.49 ± 1.74 mg/cm 2 ) than that observed with plain EGCG solution. Similar observation has been reported in previous literature where transfersomes increased the skin deposition of drugs like cyclosporin A, estradiol, dipotassium glycyrrhizinate, dexamethasone and ketotifen along with enhancement in permeation rate in their transfersomal forms due to transcutaneous hydration gradient (Maghraby et al, 1999;Guo et al, 2000;Trotta et al, 2002;Jain et al, 2003;Elsayed et al, 2007). Further enhancement in skin deposition of EGCG (38.90 ± 1.16 mg/cm 2 ) was observed with the transfersomal formulation containing both EGCG as well as HA (ETF20).…”
Section: In Vitro Skin Permeation and Deposition Studysupporting
confidence: 89%
“…12) Transfersomes are the first generation of elastic vesicles introduced by Cevc and Blune 7) and consist mainly of phospholipids and an edge activator or a single-chain surfactant which having a high radius of curvature that increases deformability of the bilayers. 13) Niosomes are the second generation of elastic vesicles introduced by van den Bergh et al 8) and compose of the optimal ration of non-ionic surfactant and cholesterol. Ethosomes are another novel vesicular carriers, developed and introduced by Touitou et al 9) and incorporate ethanol into vesicle bilayer.…”
Section: Hcl)mentioning
confidence: 99%
“…The results of an in vivo anti-inflammatory activity study showed that GA elastic vesicles had a significant reduction in ear thickness and mass (25.52 and 49.23%) ( p   <  0.05) as compared with a positive control group (triamcinolone acetonide and econazole nitrate cream in the market)[77]CatechinAntioxidentVeregen®In this study were compared catechin-loaded conventional liposomal, deformable conventional liposomal, and deformable liposomes prepared by the reverse-phase evaporation (REV) methodL-α-phosphatidylcholine, cholesterol, sodiumdeoxycholateResults suggested that all liposomal formulations exhibited a prolonged catechin release. Compared with deformable liposomes, the REV deformable liposomes showed a greater deposition of (+)-catechin while catechin solution did not permeate into the porcine ear skin[78]DipotassiumglycyrrhizinateAnti-inflammatoryagentStudied the possibility of elastic liposomes for skin release of dipotassium glycyrrhizinate (KG) for treatment of acute and chronic dermatitisSoya lecithin (PC) or hydrogenated soya lecithinDipotassium glycyrrhizinate interacted with liposomes disrupting and fluidizing the lipid bilayer, skin deposition increased 4.5-fold compared with aqueous solution while KG was formulated in liposomes[79]KetotifenAntihistaminicZaditor ketotifenIn this study were investigated possible mechanisms of deformable liposomes and ethosomes for improving skin delivery of ketotifen under non-occlusive conditionsPhosphatidylcholine,Tween-80Results suggested that both the penetration-enhancing effect and the intact vesicle permeation into the stratum corneum might play a role in improving skin delivery of drugs by deformable liposomes, under non-occlusive conditions, and that the penetration-enhancing effect was of greater importance in the case of ketotifen[80]Quercetin andresveratrolTo reduce subcutaneousfatIn this study, proposed quercetin and resveratrol-containing SDC-elastic liposomes as a new approach for dissolving the subcutaneous fatSoya phosphatidylcholine cholesterol, stearylamine, sodium deoxycholateResults showed optimized elastic quercetin and resveratrol-loaded liposomes with suitable physicochemical properties and kinetic drug profiles for subcutaneous injection[81]TetanusVaccineAdacel (Tdap)In the present study, elastic vesicle transfersomes, non-ionic surfactant vesicles (niosomes) and liposomes were used to stu...…”
Section: Methods Of Preparationmentioning
confidence: 99%